UAB Policy on Use of and Investigation with Drugs, Biologics, Devices, or Test Articles under FDA Regulations
It is UAB policy that research will include additional safeguards to protect the rights and welfare of students when students are involved in research.
When reviewing research involving students, the convened IRB or reviewer for expedited procedure will determine and document that the regulatory criteria allowing approval under 34 CFR 98 Protection of Pupil Rights Amendment (PPRA) or 34 CFR 99 Family Educational Rights Protection Act (FERPA) have been met, if applicable GUI345. Investigators are responsible for providing information for the IRB to make this determination.
Approved on October 29, 2010, by:
Richard B. Marchase, PhD
Vice President for Research and Economic Development
Ferdinand Urthaler, MD
Sheila Deters Moore, CIP